Organigram Inc. joined Bedrocan (BED) on  Monday as another licensed Canadian medical cannabis cultivation company to become a publicly traded licensed producer under Canada’s Marijuana for Medical Purposes Regulations (MMPR), offering investors an alternative to Tweed (TWD) in the budding market.

 After completing its reverse merger and a mandatory trading halt, investors can now purchase the stock under the ticker symbol “OGI”.

Canada’s medical marijuana market is expected to grow from $179 million to $1.34 billion over the next ten years, according to Health Canada, with the patient population jumping from 41,384 to 308,755. With only 13 licensed producers approved to date, investors in OrganiGram have a unique opportunity to capitalize on the growing demand at a very early stage for the industry.

Read Full Story On: cannabisfn


Leave a Reply

Your email address will not be published. Required fields are marked *

About Canna Magazine

This is the “wpengine” admin user that our staff uses to gain access to your admin area to provide support and troubleshooting. It can only be accessed by a button in our secure log that auto generates a password and dumps that password after the staff member has logged in. We have taken extreme measures to ensure that our own user is not going to be misused to harm any of our clients sites.

Category

Global News, Investing

Tags

, , , ,